IDEX Financials

IEX

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 75/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

100

IDEX has an operating margin of 20.7%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is down from 22.4% the prior year.

Growth

IDEX's revenue declined 0.2% year-over-year, from $3.3B to $3.3B. This contraction results in a growth score of 28/100.

Leverage

IDEX carries a low D/E ratio of 0.49, meaning only $0.49 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 2.53, IDEX holds $2.53 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 81/100.

Cash Flow

IDEX converts 18.4% of revenue into free cash flow ($603.0M). This strong cash generation earns a score of 92/100.

Returns

IDEX's ROE of 13.3% shows moderate profitability relative to equity, earning a score of 53/100. This is down from 16.8% the prior year.

Altman Z-Score Safe

5.07

IDEX scores 5.07, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($15.7B) relative to total liabilities ($3.0B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

4/9

IDEX passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.32x

For every $1 of reported earnings, IDEX generates $1.32 in operating cash flow ($668.1M OCF vs $505.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

This page shows IDEX (IEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$3.3B

YoY-0.2%

5Y CAGR+5.6%

10Y CAGR+4.3%

IDEX generated $3.3B in revenue in fiscal year 2024. This represents a decrease of 0.2% from the prior year.

EBITDA

$852.8M

YoY-3.6%

5Y CAGR+5.4%

10Y CAGR+5.3%

IDEX's EBITDA was $852.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 3.6% from the prior year.

Free Cash Flow

$603.0M

YoY-3.8%

5Y CAGR+4.8%

10Y CAGR+6.5%

IDEX generated $603.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 3.8% from the prior year.

Net Income

$505.0M

YoY-15.3%

5Y CAGR+3.5%

10Y CAGR+6.1%

IDEX reported $505.0M in net income in fiscal year 2024. This represents a decrease of 15.3% from the prior year.

EPS (Diluted)

$6.64

YoY-15.4%

5Y CAGR+3.6%

10Y CAGR+6.8%

IDEX earned $6.64 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 15.4% from the prior year.

Cash & Debt

$620.8M

YoY+16.2%

5Y CAGR-0.4%

10Y CAGR+2.0%

IDEX held $620.8M in cash against $1.9B in long-term debt as of fiscal year 2024.

Dividends Per Share

$2.76

YoY+7.8%

5Y CAGR+6.7%

10Y CAGR+9.4%

IDEX paid $2.76 per share in dividends in fiscal year 2024. This represents an increase of 7.8% from the prior year.

Shares Outstanding

76M

IDEX had 76M shares outstanding in fiscal year 2024.

Gross Margin

44.2%

YoY+0.0pp

5Y CAGR-0.9pp

10Y CAGR+0.0pp

IDEX's gross margin was 44.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 0.0 percentage points from the prior year.

Operating Margin

20.7%

YoY-1.7pp

5Y CAGR-2.5pp

10Y CAGR+0.6pp

IDEX's operating margin was 20.7% in fiscal year 2024, reflecting core business profitability. This is down 1.7 percentage points from the prior year.

Net Margin

15.4%

YoY-2.8pp

5Y CAGR-1.6pp

10Y CAGR+2.4pp

IDEX's net profit margin was 15.4% in fiscal year 2024, showing the share of revenue converted to profit. This is down 2.8 percentage points from the prior year.

Return on Equity

13.3%

YoY-3.5pp

5Y CAGR-5.5pp

10Y CAGR-5.5pp

IDEX's ROE was 13.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 3.5 percentage points from the prior year.

R&D Spending

$67.4M

YoY-1.5%

5Y CAGR+3.6%

10Y CAGR+6.2%

IDEX invested $67.4M in research and development in fiscal year 2024. This represents a decrease of 1.5% from the prior year.

Share Buybacks

YoY-100.0%

IDEX spent $0 on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$65.1M

YoY-27.6%

5Y CAGR+5.0%

10Y CAGR+3.1%

IDEX invested $65.1M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 27.6% from the prior year.

IEX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$3.3B-0.2%	$3.3B+2.9%	$3.2B+15.1%	$2.8B+17.6%	$2.4B-5.7%	$2.5B
Cost of Revenue	$1.8B-0.2%	$1.8B+4.1%	$1.8B+13.9%	$1.5B+16.3%	$1.3B-3.3%	$1.4B
Gross Profit	$1.4B-0.1%	$1.4B+1.4%	$1.4B+16.5%	$1.2B+19.2%	$1.0B-8.7%	$1.1B
R&D Expenses	$67.4M-1.5%	$68.4M+11.4%	$61.4M+22.6%	$50.1M+3.9%	$48.2M-14.5%	$56.4M
SG&A Expenses	$758.7M+7.8%	$703.5M+7.8%	$652.7M+12.9%	$578.2M+16.8%	$494.9M-5.7%	$525.0M
Operating Income	$677.2M-7.5%	$732.5M-2.5%	$751.4M+18.0%	$637.0M+22.3%	$520.7M-10.1%	$579.0M
Interest Expense	N/A	$51.7M+27.0%	$40.7M-0.7%	$41.0M-8.5%	$44.8M+1.1%	$44.3M
Income Tax	$134.7M-18.2%	$164.7M+1.2%	$162.7M+24.7%	$130.5M+41.1%	$92.5M-13.9%	$107.4M
Net Income	$505.0M-15.3%	$596.1M+1.6%	$586.9M+30.6%	$449.4M+19.0%	$377.8M-11.2%	$425.5M
EPS (Diluted)	$6.64-15.4%	$7.85+1.8%	$7.71+31.1%	$5.88+19.0%	$4.94-11.2%	$5.56

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$878.7M+1.5%	$865.4M+6.3%	$814.3M-5.6%	$862.9M+6.9%	$807.2M+0.8%	$800.5M+1.5%	$788.9M-0.6%	$793.4M
Cost of Revenue	$488.1M+3.1%	$473.2M+6.2%	$445.4M-10.2%	$495.8M+12.6%	$440.4M-0.6%	$443.1M-2.0%	$452.1M+1.9%	$443.8M
Gross Profit	$390.6M-0.4%	$392.2M+6.3%	$368.9M+0.5%	$367.1M+0.1%	$366.8M+2.6%	$357.4M+6.1%	$336.8M-3.7%	$349.6M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$204.7M+0.5%	$203.6M-2.8%	$209.4M+5.8%	$197.9M+8.3%	$182.8M-6.3%	$195.1M+12.4%	$173.6M+4.6%	$165.9M
Operating Income	$185.8M-1.1%	$187.9M+32.3%	$142.0M-14.1%	$165.3M-9.5%	$182.7M+13.3%	$161.2M+0.4%	$160.5M-10.6%	$179.6M
Interest Expense	N/A	N/A	N/A	$10.3M+27.2%	$8.1M-13.8%	$9.4M-19.0%	$11.6M-15.3%	$13.7M
Income Tax	$42.8M+10.3%	$38.8M+33.3%	$29.1M+3.9%	$28.0M-26.3%	$38.0M+14.5%	$33.2M+4.1%	$31.9M-39.6%	$52.8M
Net Income	$127.8M-2.9%	$131.6M+37.8%	$95.5M-22.5%	$123.2M-12.8%	$141.3M+16.4%	$121.4M+11.8%	$108.6M-48.1%	$209.1M
EPS (Diluted)	$1.70-2.3%	$1.74+38.1%	$1.26-21.7%	$1.61-13.4%	$1.86+16.3%	$1.60+11.1%	$1.44-47.6%	$2.75

IEX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$6.7B+15.0%	$5.9B+6.4%	$5.5B+12.1%	$4.9B+11.4%	$4.4B+15.7%	$3.8B
Current Assets	$1.6B+10.1%	$1.4B+3.4%	$1.4B-16.6%	$1.7B+1.3%	$1.7B+31.4%	$1.3B
Cash & Equivalents	$620.8M+16.2%	$534.3M+24.2%	$430.2M-49.7%	$855.4M-16.6%	$1.0B+62.2%	$632.6M
Inventory	$429.7M+2.1%	$420.8M-10.6%	$470.9M+27.1%	$370.4M+27.8%	$289.9M-1.2%	$293.5M
Accounts Receivable	$461.0M+10.0%	$419.0M-2.9%	$431.3M+21.5%	$354.9M+23.1%	$288.3M-3.3%	$298.1M
Goodwill	$3.3B+14.6%	$2.8B+7.6%	$2.6B+21.7%	$2.2B+14.4%	$1.9B+6.5%	$1.8B
Total Liabilities	$3.0B+27.0%	$2.3B-6.0%	$2.5B+16.9%	$2.1B+12.8%	$1.9B+20.9%	$1.6B
Current Liabilities	$629.7M+25.9%	$500.3M-8.0%	$543.6M+13.3%	$480.0M+20.3%	$399.0M+11.5%	$357.9M
Long-Term Debt	$1.9B+40.3%	$1.3B-9.8%	$1.5B+23.4%	$1.2B+14.0%	$1.0B+23.0%	$848.9M
Total Equity	$3.8B+7.2%	$3.5B+16.5%	$3.0B+8.4%	$2.8B+10.3%	$2.5B+12.2%	$2.3B
Retained Earnings	$4.2B+7.5%	$3.9B+11.4%	$3.5B+13.0%	$3.1B+10.0%	$2.8B+8.7%	$2.6B

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$7.0B+1.4%	$6.9B+1.2%	$6.8B+0.7%	$6.7B+14.3%	$5.9B+0.2%	$5.9B+0.4%	$5.9B+3.4%	$5.7B
Current Assets	$1.7B+2.4%	$1.6B-0.6%	$1.6B+2.1%	$1.6B-2.3%	$1.6B+4.8%	$1.6B+7.5%	$1.4B-4.7%	$1.5B
Cash & Equivalents	$593.8M+4.5%	$568.2M-4.4%	$594.1M-4.3%	$620.8M-11.4%	$700.7M+13.7%	$616.3M+15.3%	$534.3M-5.0%	$562.7M
Inventory	$495.1M+1.5%	$487.8M+4.6%	$466.3M+8.5%	$429.7M+0.4%	$427.9M+0.4%	$426.0M+1.2%	$420.8M-5.8%	$446.6M
Accounts Receivable	$488.7M+4.3%	$468.5M-1.4%	$475.3M+3.1%	$461.0M+10.8%	$416.1M-3.0%	$429.1M+2.4%	$419.0M-0.9%	$422.8M
Goodwill	$3.4B+1.2%	$3.4B+2.5%	$3.3B+1.1%	$3.3B+16.7%	$2.8B-0.6%	$2.8B-1.2%	$2.8B+6.0%	$2.7B
Total Liabilities	$3.0B+3.3%	$2.9B-0.8%	$2.9B-2.1%	$3.0B+31.2%	$2.2B-0.9%	$2.3B-2.3%	$2.3B+1.8%	$2.3B
Current Liabilities	$564.0M+6.5%	$529.8M-9.2%	$583.6M-7.3%	$629.7M+31.9%	$477.4M+3.6%	$460.6M-7.9%	$500.3M+2.6%	$487.5M
Long-Term Debt	$1.9B+3.0%	$1.8B+0.4%	$1.8B-1.1%	$1.9B+43.3%	$1.3B-1.9%	$1.3B-0.2%	$1.3B+0.3%	$1.3B
Total Equity	$4.0B0.0%	$4.0B+2.7%	$3.9B+2.9%	$3.8B+3.9%	$3.7B+1.0%	$3.6B+2.2%	$3.5B+4.6%	$3.4B
Retained Earnings	$4.4B+1.7%	$4.4B+0.6%	$4.3B+2.3%	$4.2B+3.4%	$4.1B+0.9%	$4.1B+3.1%	$3.9B+1.6%	$3.9B

IEX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$668.1M-6.8%	$716.7M+28.6%	$557.4M-1.4%	$565.3M-0.7%	$569.3M+7.8%	$528.1M
Capital Expenditures	$65.1M-27.6%	$89.9M+32.2%	$68.0M-6.5%	$72.7M+40.9%	$51.6M+1.4%	$50.9M
Free Cash Flow	$603.0M-3.8%	$626.8M+28.1%	$489.4M-0.6%	$492.6M-4.8%	$517.7M+8.5%	$477.2M
Investing Cash Flow	-$1.0B-254.7%	-$283.8M+69.1%	-$917.2M-31.4%	-$698.1M-304.5%	-$172.6M-26.0%	-$137.0M
Financing Cash Flow	$465.9M+235.2%	-$344.7M-811.9%	-$37.8M-297.9%	-$9.5M+77.7%	-$42.6M+81.3%	-$227.6M
Dividends Paid	$205.3M+7.7%	$190.7M+7.5%	$177.4M+10.1%	$161.1M+6.1%	$151.8M+3.1%	$147.2M
Share Buybacks	$0-100.0%	$24.2M-83.7%	$148.1M	$0-100.0%	$110.3M+101.6%	$54.7M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$203.5M+25.9%	$161.7M+53.0%	$105.7M-38.8%	$172.6M+29.2%	$133.6M-14.7%	$156.6M-22.1%	$201.0M-11.3%	$226.6M
Capital Expenditures	$14.8M0.0%	$14.8M+3.5%	$14.3M-7.7%	$15.5M-2.5%	$15.9M-20.5%	$20.0M-7.4%	$21.6M+7.5%	$20.1M
Free Cash Flow	$188.7M+28.5%	$146.9M+60.7%	$91.4M-41.8%	$157.1M+33.5%	$117.7M-13.8%	$136.6M-23.9%	$179.4M-13.1%	$206.5M
Investing Cash Flow	-$95.5M-558.6%	-$14.5M-45.0%	-$10.0M+32.0%	-$14.7M-146.4%	$31.7M+258.5%	-$20.0M+89.7%	-$193.8M-323.8%	$86.6M
Financing Cash Flow	-$75.7M+64.9%	-$215.9M-62.0%	-$133.3M+5.3%	-$140.8M-82.4%	-$77.2M-88.3%	-$41.0M+29.3%	-$58.0M+70.2%	-$194.7M
Dividends Paid	$53.5M0.0%	$53.5M+2.1%	$52.4M+0.2%	$52.3M+0.2%	$52.2M+7.6%	$48.5M+0.2%	$48.4M0.0%	$48.4M
Share Buybacks	$75.0M+50.0%	$50.0M0.0%	$50.0M	$0	$0	$0-100.0%	$23.1M+23000.0%	$100K

IEX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	44.2%+0.0pp	44.2%-0.7pp	44.8%+0.6pp	44.3%+0.6pp	43.7%-1.4pp	45.1%
Operating Margin	20.7%-1.7pp	22.4%-1.2pp	23.6%+0.6pp	23.0%+0.9pp	22.1%-1.1pp	23.2%
Net Margin	15.4%-2.8pp	18.2%-0.2pp	18.4%+2.2pp	16.3%+0.2pp	16.1%-1.0pp	17.1%
Return on Equity	13.3%-3.5pp	16.8%-2.5pp	19.3%+3.3pp	16.0%+1.2pp	14.9%-3.9pp	18.8%
Return on Assets	7.5%-2.7pp	10.2%-0.5pp	10.7%+1.5pp	9.1%+0.6pp	8.6%-2.6pp	11.2%
Current Ratio	2.53-0.4	2.89+0.3	2.57-0.9	3.50-0.7	4.15+0.6	3.52
Debt-to-Equity	0.49+0.1	0.37-0.1	0.48+0.1	0.42+0.0	0.41+0.0	0.38
FCF Margin	18.4%-0.7pp	19.1%+3.8pp	15.4%-2.4pp	17.8%-4.2pp	22.0%+2.9pp	19.1%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	44.5%-0.9pp	45.3%+0.0pp	45.3%+2.8pp	42.5%-2.9pp	45.4%+0.8pp	44.6%+2.0pp	42.7%-1.4pp	44.1%
Operating Margin	21.1%-0.6pp	21.7%+4.3pp	17.4%-1.7pp	19.2%-3.5pp	22.6%+2.5pp	20.1%-0.2pp	20.3%-2.3pp	22.6%
Net Margin	14.5%-0.7pp	15.2%+3.5pp	11.7%-2.6pp	14.3%-3.2pp	17.5%+2.3pp	15.2%+1.4pp	13.8%-12.6pp	26.4%
Return on Equity	3.2%-0.1pp	3.3%+0.8pp	2.4%-0.8pp	3.3%-0.6pp	3.9%+0.5pp	3.4%+0.3pp	3.1%-3.1pp	6.2%
Return on Assets	1.8%-0.1pp	1.9%+0.5pp	1.4%-0.4pp	1.8%-0.6pp	2.4%+0.3pp	2.1%+0.2pp	1.8%-1.8pp	3.7%
Current Ratio	2.93-0.1	3.05+0.3	2.79+0.3	2.53-0.9	3.41+0.0	3.37+0.5	2.89-0.2	3.11
Debt-to-Equity	0.47+0.0	0.46-0.0	0.47-0.0	0.49+0.1	0.36-0.0	0.370.0	0.37-0.0	0.39
FCF Margin	21.5%+4.5pp	17.0%+5.8pp	11.2%-7.0pp	18.2%+3.6pp	14.6%-2.5pp	17.1%-5.7pp	22.7%-3.3pp	26.0%

Similar Companies

$15.7B

$16.6B

$11.5B

$17.5B

$11.1B

Frequently Asked Questions

What is IDEX's annual revenue?

IDEX (IEX) reported $3.3B in total revenue for fiscal year 2024. This represents a -0.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is IDEX's revenue growing?

IDEX (IEX) revenue declined by 0.2% year-over-year, from $3.3B to $3.3B in fiscal year 2024.

Is IDEX profitable?

Yes, IDEX (IEX) reported a net income of $505.0M in fiscal year 2024, with a net profit margin of 15.4%.

What is IDEX's earnings per share (EPS)?

IDEX (IEX) reported diluted earnings per share of $6.64 for fiscal year 2024. This represents a -15.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is IDEX's EBITDA?

IDEX (IEX) had EBITDA of $852.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does IDEX have?

As of fiscal year 2024, IDEX (IEX) had $620.8M in cash and equivalents against $1.9B in long-term debt.

What is IDEX's gross margin?

IDEX (IEX) had a gross margin of 44.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is IDEX's operating margin?

IDEX (IEX) had an operating margin of 20.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is IDEX's net profit margin?

IDEX (IEX) had a net profit margin of 15.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does IDEX pay dividends?

Yes, IDEX (IEX) paid $2.76 per share in dividends during fiscal year 2024.

What is IDEX's return on equity (ROE)?

IDEX (IEX) has a return on equity of 13.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is IDEX's free cash flow?

IDEX (IEX) generated $603.0M in free cash flow during fiscal year 2024. This represents a -3.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is IDEX's operating cash flow?

IDEX (IEX) generated $668.1M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are IDEX's total assets?

IDEX (IEX) had $6.7B in total assets as of fiscal year 2024, including both current and long-term assets.

What are IDEX's capital expenditures?

IDEX (IEX) invested $65.1M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does IDEX spend on research and development?

IDEX (IEX) invested $67.4M in research and development during fiscal year 2024.

How many shares does IDEX have outstanding?

IDEX (IEX) had 76M shares outstanding as of fiscal year 2024.

What is IDEX's current ratio?

IDEX (IEX) had a current ratio of 2.53 as of fiscal year 2024, which is generally considered healthy.

What is IDEX's debt-to-equity ratio?

IDEX (IEX) had a debt-to-equity ratio of 0.49 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is IDEX's return on assets (ROA)?

IDEX (IEX) had a return on assets of 7.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is IDEX's Altman Z-Score?

IDEX (IEX) has an Altman Z-Score of 5.07, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is IDEX's Piotroski F-Score?

IDEX (IEX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are IDEX's earnings high quality?

IDEX (IEX) has an earnings quality ratio of 1.32x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is IDEX?

IDEX (IEX) scores 75 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.